Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human NMU ELISA Kit (AC3644)
Cat.#: ASET-2233
Specifications
Description Human NMU ELISA Kit allows for the in vitro quantitative determination of human NMU concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 46.875 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 78.125-5000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1073 Human FGFR4 ELISA Kit (AC2484) Quantitative inquiry ASET-2287 Human HMT ELISA Kit (AC3698) Quantitative inquiry ASET-2477 Porcine Slit2 ELISA Kit (AC3888) Quantitative inquiry ASET-2295 Rat GABA ELISA Kit (AC3706) Quantitative inquiry ASET-1812 Human Dynamin 2 ELISA Kit (AC3223) Quantitative inquiry ASET-1724 Mouse LAMP1 ELISA Kit (AC3135) Quantitative inquiry ASET-1958 Human P311 ELISA Kit (AC3369) Quantitative inquiry ASET-1634 Human Adenosine Receptor A2a ELISA Kit (AC3045) Quantitative inquiry ASET-1388 Mouse Adenosine Receptor A2a ELISA Kit (AC2799) Quantitative inquiry ASET-1809 Human Ephrin B2 ELISA Kit (AC3220) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket